CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
CAV Regimen for R/R AML
- Status
- RECRUITING
- Phase
- PHASE2
CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
- Status
- RECRUITING
- Phase
- PHASE1
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
- Status
- RECRUITING
- Phase
- PHASE1
ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML
- Status
- WITHDRAWN
- Phase
- PHASE1
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study
- Status
- WITHDRAWN
- Phase
- NA
Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
- Status
- AVAILABLE
- Phase
- N/A
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2